Destination Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Destination Wealth Management's GILD Position: Q2 2026 in Review
Destination Wealth Management reduced its Gilead Sciences (GILD) stake by 15% in Q2 2026, selling an estimated $92.2K and leaving 3,997 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #215.
Destination Wealth Management first reported a position in GILD in Q1 2017 and has held it in 15 quarters since. The position peaked at $655K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Destination Wealth Management held 3,997 shares of Gilead Sciences worth $505K as of Q2 2026.
- Destination Wealth Management sold 700 Gilead Sciences shares in Q2 2026, an estimated $92.2K.
- Gilead Sciences made up 0.01% of Destination Wealth Management's portfolio in Q2 2026, its #215 holding.
- Destination Wealth Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 15 quarters since.
- Destination Wealth Management's Gilead Sciences position peaked at $655K in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Destination Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.